CD44 is a CSC gene and has been observed to be highly expressed in the poorly differentiated metastatic stages of oral cancer patients, leading to invasion, malignancy, and poor prognosis [43]. The gene discussed is CD44; the disease is lip and oral cavity carcinoma.